IP Library Granted Patent US 10,456,574
Granted Patent B2
US 10,456,574 · App. 15/594,841 · Granted Oct 29, 2019

Systems and methods for reducing power consumption in an implantable medical device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,456,574
App. No.
15/594,841
Granted
Oct 29, 2019
Kind
B2
Abstract

A medical device includes telemetry circuitry configured to receive programming instructions. The medical device also includes stimulation circuitry configured to generate a plurality of electrical pulses in response to the programming instructions to provide an electrical stimulation therapy for a patient. The stimulation circuitry includes a voltage converter, a multiplexor, and a stimulation driver. At least one of the voltage converter, the multiplexer, or the stimulation driver is selectively enabled and disabled during or between the electrical pulses to reduce power consumption of the medical device.

Claims (62)

1. A medical device, comprising:

telemetry circuitry configured to receive programming instructions; and

stimulation circuitry configured to generate a plurality of electrical pulses in response to the programming instructions to provide an electrical stimulation therapy for a patient; and a microcontroller configured to generate control signals; wherein: each electrical pulse includes a primary phase, an interphase after the primary phase, and a recovery phase after the primary phase; a standby period exists between any two consecutive electrical pulses; the stimulation circuitry includes a voltage converter, a multiplexer, and a stimulation driver; and the control signals generated by the microcontroller selectively enable or disable at least one of the voltage converter, the multiplexer, or the stimulation driver during the primary phase, the interphase, the recovery phase, or the standby period to reduce power consumption of the medical device.

2. The medical device of claim 1 , wherein the multiplexer is disabled during the interphase.

3. The medical device of claim 2 , wherein the multiplexer is disabled during the standby period.

4. The medical device of claim 1 , wherein:

the recovery phase is a passive recovery phase;

the voltage converter and the stimulation driver are disabled during the passive recovery phase; and

the voltage converter and the stimulation driver are disabled at least partially during the interphase and the standby period.

5. The medical device of claim 4 , wherein:

the microcontroller is enabled during the primary phase; and

the microcontroller is disabled during the passive recovery phase and at least partially during the interphase and the standby period.

6. The medical device of claim 1 , wherein:

the recovery phase is an active recovery phase;

the voltage converter and the stimulation driver are enabled during the primary phase, the interphase, and the active recovery phase; and

the voltage converter and the stimulation driver are disabled at least partially during the standby period.

7. The medical device of claim 6 , wherein:

the stimulation circuitry further includes a microcontroller configured to generate control signals to selectively enable and disable the voltage converter, the multiplexer, or the stimulation driver;

the microcontroller is enabled during the primary phase, the interphase, and the active recovery phase; and

the microcontroller is disabled at least partially during the standby period.

8. A method, comprising:

receiving programming instructions via telemetry circuitry of a pulse generator; and

generating, via stimulation circuitry of the pulse generator that includes a voltage converter, a multiplexer, and a stimulation driver, a plurality of electrical pulses in response to the programming instructions to provide an electrical stimulation therapy for a patient, wherein the generating comprises automatically enabling and disabling the voltage converter, the multiplexer, or the stimulation driver during or between the electrical pulses to reduce power consumption of the pulse generator; wherein: each electrical pulse includes a primary phase, an interphase after the primary phase, and a recovery phase after the primary phase; a standby period exists between any two consecutive electrical pulses; and the automatically enabling and disabling comprises selectively enabling or disabling at least one of the voltage converter, the multiplexer, or the stimulation driver during the primary phase, the interphase, the recovery phase, or the standby period.

9. The method of claim 8 , wherein the automatically enabling and disabling comprises automatically disabling the multiplexer during the interphase.

10. The method of claim 9 , wherein the automatically enabling and disabling further comprises automatically disabling the multiplexer during the standby period.

11. The method of claim 8 , wherein:

the recovery phase is a passive recovery phase;

the automatically enabling and disabling comprises automatically disabling the voltage converter and the stimulation driver during the passive recovery phase; and

the automatically enabling and disabling comprises automatically disabling the voltage converter and the stimulation driver at least partially during the interphase and the standby period.

12. The method of claim 11 , wherein:

the stimulation circuitry further includes a microcontroller configured to generate control signals to selectively enable and disable the voltage converter, the multiplexer, or the stimulation driver;

the automatically enabling and disabling comprises automatically enabling the microcontroller during the primary phase; and

the automatically enabling and disabling comprises automatically disabling the microcontroller during the passive recovery phase and at least partially during the interphase and the standby period.

13. The method of claim 8 , wherein:

the recovery phase is an active recovery phase;

the automatically enabling and disabling comprises automatically enabling the voltage converter and the stimulation driver during the primary phase, the interphase, and the active recovery phase; and

the automatically enabling and disabling comprises automatically disabling the voltage converter and the stimulation driver at least partially during the standby period.

14. The method of claim 13 , wherein:

the stimulation circuitry further includes a microcontroller configured to generate control signals to selectively enable and disable the voltage converter, the multiplexer, or the stimulation driver;

the automatically enabling and disabling comprises automatically enabling the microcontroller during the primary phase, the interphase, and the active recovery phase; and

the automatically enabling and disabling comprises automatically disabling the microcontroller at least partially during the standby period.

15. A medical device, comprising:

telemetry circuitry configured to receive programming instructions; and

stimulation circuitry configured to generate a plurality of electrical pulses in response to the programming instructions to provide an electrical stimulation therapy for a patient, wherein each electrical pulse includes a primary phase, an interphase after the primary phase, and a recovery phase after the primary phase, and wherein a standby period exists between any two consecutive electrical pulses;

wherein:

the stimulation circuitry includes a voltage converter, a multiplexer, and a stimulation driver; and

at least one of the voltage converter, the multiplexer, or the stimulation driver is selectively disabled during the primary phase, the interphase, the recovery phase, or the standby period.

16. The medical device of claim 15 , wherein the multiplexer is disabled during the interphase or during the standby period.

17. The medical device of claim 15 , wherein:

the recovery phase is a passive recovery phase;

the voltage converter and the stimulation driver are disabled during the passive recovery phase;

the voltage converter and the stimulation driver are disabled at least partially during the interphase and the standby period;

the stimulation circuitry further includes a microcontroller configured to generate control signals to selectively enable and disable the voltage converter, the multiplexer, or the stimulation driver;

the microcontroller is enabled during the primary phase; and

the microcontroller is disabled during the passive recovery phase and at least partially during the interphase and the standby period.

18. The medical device of claim 15 , wherein:

the recovery phase is an active recovery phase;

the voltage converter and the stimulation driver are enabled during the primary phase, the interphase, and the active recovery phase;

the voltage converter and the stimulation driver are disabled at least partially during the standby period;

the stimulation circuitry further includes a microcontroller configured to generate control signals to selectively enable and disable the voltage converter, the multiplexer, or the stimulation driver;

the microcontroller is enabled during the primary phase, the interphase, and the active recovery phase; and

the microcontroller is disabled at least partially during the standby period.

Assignments (2)
SECURITY INTEREST Recorded Sep 10, 2021
From: GREATBATCH LTD.; ELECTROCHEM SOLUTIONS, INC.; LAKE REGION MEDICAL, INC.; LAKE REGION MANUFACTURING, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 057468/0056 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2017
From: CHEN, JOEY; BRADLEY, KERRY; HALBERG, LESLIE
To: GREATBATCH LTD.
Reel/Frame 042376/0314 →